cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives

Reuters

2025/10/02

cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives

cbdMD, Inc. (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2572557555"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572557555\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572557555?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 04:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572557555","market":"us","top_or_hot":-1,"title":"cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/YCBD\">cbdMD, Inc.</a> (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\ncbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-02 04:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/YCBD\">cbdMD, Inc.</a> (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL7zy1vH:1","article_id":"2572557555","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572557555","pubTimestamp":1759349760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"cbdMD, Inc. , a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes onl","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","YCBD":"cbdMD, Inc."},"translate_title":"cbdMD Inc.在B轮优先私募中筹集170万美元以支持增长计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YCBD":0.9},"content_text":"cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n    \n\ncbdMD, Inc. (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}